-
Something wrong with this record ?
Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations
S. Pruhova, P. Dusatkova, Z. Sumnik, S. Kolouskova, O. Pedersen, T. Hansen, O. Cinek, J. Lebl
Language English Country Denmark
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Protein Denaturation MeSH
- Diabetes Mellitus, Type 2 genetics MeSH
- Child MeSH
- Glucokinase genetics MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Mutation MeSH
- Prevalence MeSH
- Chromatography, High Pressure Liquid methods MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: Glucokinase diabetes, also called GCK-MODY or maturity-onset diabetes of the young type 2 (MODY2), is caused by heterozygous mutations in the gene encoding glucokinase (GCK). Objective: The aim of study was to investigate the current prevalence of GCK mutations in a large cohort of Czech patients with typical clinical appearance of GCK-MODY. In addition, we reanalyzed the negative results obtained previously by screening using the denaturing high-performance liquid chromatography (dHPLC). METHODS: We studied 140 unrelated Czech probands with clinical picture of GCK-MODY who were referred to our center from the whole of the Czech Republic between the years 1999-2009 by direct sequencing of GCK gene. RESULTS: A mutation in GCK was identified in 103 of 140 probands (74%). We identified 46 different GCK mutations of which 13 were novel. Several mutations were detected in multiple families: p.Glu40Lys (20 families), p.Gly318Arg (12), p.Leu315His (7) and p.Val33Ala (six families). Direct sequencing detected a GCK mutations in 9 of 20 previously dHPLC-negative samples; the sensitivity of the dHPLC screening was calculated as 84%. CONCLUSIONS: The study shows a relatively high proportion of GCK mutations among individuals with GCK-like phenotype, confirming the effectiveness of carefully applied clinical criteria prior to genetic testing. In the Czech MODY registry, GCK-MODY represents the biggest subgroup of MODY (35%). We report several prevalent GCK mutations with a likely founder effect in the Czech population. Furthermore, our results provide ground for a possible recommendation to reinspect all negative results previously obtained by screening using dHPLC.
Department of Pediatrics University Hospital Motol Charles University Prague Prague Czech Republic
Hagedorn Research Institute and Steno Diabetes Center Gentofte Denmark
Institute of Biomedical Sciences University of Copenhagen Copenhagen Denmark
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12026951
- 003
- CZ-PrNML
- 005
- 20160601082711.0
- 007
- ta
- 008
- 120816s2010 dk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1399-5448.2010.00646.x $2 doi
- 035 __
- $a (PubMed)20337973
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Průhová, Štěpánka, $d 1974- $7 mzk2004252387 $u Department of Pediatrics, University Hospital Motol, Charles University in Prague, Prague, Czech Republic; Department of Pediatrics, University Hospital Kralovske Vinohrady, Charles University in Prague, Prague, Czech Republic
- 245 10
- $a Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations / $c S. Pruhova, P. Dusatkova, Z. Sumnik, S. Kolouskova, O. Pedersen, T. Hansen, O. Cinek, J. Lebl
- 520 9_
- $a BACKGROUND: Glucokinase diabetes, also called GCK-MODY or maturity-onset diabetes of the young type 2 (MODY2), is caused by heterozygous mutations in the gene encoding glucokinase (GCK). Objective: The aim of study was to investigate the current prevalence of GCK mutations in a large cohort of Czech patients with typical clinical appearance of GCK-MODY. In addition, we reanalyzed the negative results obtained previously by screening using the denaturing high-performance liquid chromatography (dHPLC). METHODS: We studied 140 unrelated Czech probands with clinical picture of GCK-MODY who were referred to our center from the whole of the Czech Republic between the years 1999-2009 by direct sequencing of GCK gene. RESULTS: A mutation in GCK was identified in 103 of 140 probands (74%). We identified 46 different GCK mutations of which 13 were novel. Several mutations were detected in multiple families: p.Glu40Lys (20 families), p.Gly318Arg (12), p.Leu315His (7) and p.Val33Ala (six families). Direct sequencing detected a GCK mutations in 9 of 20 previously dHPLC-negative samples; the sensitivity of the dHPLC screening was calculated as 84%. CONCLUSIONS: The study shows a relatively high proportion of GCK mutations among individuals with GCK-like phenotype, confirming the effectiveness of carefully applied clinical criteria prior to genetic testing. In the Czech MODY registry, GCK-MODY represents the biggest subgroup of MODY (35%). We report several prevalent GCK mutations with a likely founder effect in the Czech population. Furthermore, our results provide ground for a possible recommendation to reinspect all negative results previously obtained by screening using dHPLC.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a diabetes mellitus 2. typu $x genetika $7 D003924
- 650 _2
- $a glukokinasa $x genetika $7 D005941
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a denaturace proteinů $7 D011489
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dušátková, Petra, $d 1983- $7 xx0152579 $u Department of Pediatrics, University Hospital Motol, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Šumník, Zdeněk, $d 1970- $7 xx0036973 $u Department of Pediatrics, University Hospital Motol, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Koloušková, Stanislava, $d 1956- $7 xx0003804 $u Department of Pediatrics, University Hospital Motol, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Pedersen, Oluf $u Hagedorn Research Institute & Steno Diabetes Center, Gentofte, Denmark; University of Aarhus, Aarhus, Denmark; Institute of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
- 700 1_
- $a Hansen, Torben $u Hagedorn Research Institute & Steno Diabetes Center, Gentofte, Denmark; University of Southern Denmark, Odense, Denmark
- 700 1_
- $a Cinek, Ondřej, $d 1972- $7 nlk20050167617 $u Department of Pediatrics, University Hospital Motol, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Lebl, Jan, $d 1955- $7 jn19990010093 $u Department of Pediatrics, University Hospital Motol, Charles University in Prague, Prague, Czech Republic
- 773 0_
- $w MED00181048 $t Pediatric diabetes $x 1399-5448 $g Roč. 11, č. 8 (2010), s. 529-535
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20337973 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20160601082834 $b ABA008
- 999 __
- $a ok $b bmc $g 948993 $s 784297
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 11 $c 8 $d 529-535 $i 1399-5448 $m Pediatric diabetes $n Pediatr Diabetes $x MED00181048
- LZP __
- $b NLK122 $a Pubmed-20120816/11/01
